Mesenchymal stromal cell therapy for rehabilitation after hip fracture.

2024-517010-15-01 Protocol KS-BM-MSC-HF-001 Human pharmacology (Phase I) - Other Authorised, recruitment pending

Status Authorised, recruitment pending · 1 EU/EEA countries · 1 sites · Protocol KS-BM-MSC-HF-001

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Authorised, recruitment pending
Participants planned 10
Countries 1
Sites 1

Post-operative recovery after hip fracture surgery in frail elderly patients.

Key facts

Sponsor
Karolinska University Hospital
Participant type
Patients
Age range
65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Musculoskeletal Diseases [C05], Not possible to specify
Decision date (initial)
2025-05-05
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Post-operative recovery after hip fracture surgery in frail elderly patients.

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Karolinska University Hospital

Sponsor organisation
Karolinska University Hospital
Address
Eugeniavagen 3
City
Solna
Postcode
171 64
Country
Sweden

Scientific contact point

Organisation
Karolinska University Hospital
Contact name
Margareta Hedström

Public contact point

Organisation
Karolinska University Hospital
Contact name
Margareta Hedström

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Sweden Authorised, recruitment pending 10 1
Rest of world 0

Investigational sites

Sweden

1 site · Authorised, recruitment pending
Karolinska University Hospital
Clintec, Halsovagen, Flemingsberg, Huddinge

Application history

4 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-12-20 Sweden Acceptable with conditions
2025-04-29
2025-05-05
2 SUBSTANTIAL MODIFICATION SM-1 2025-05-28 Sweden Acceptable with conditions 2025-08-04
3 SUBSTANTIAL MODIFICATION SM-2 2025-06-02 Sweden Acceptable with conditions 2025-07-07
4 SUBSTANTIAL MODIFICATION SM-3 2025-12-15 Sweden Acceptable
2026-01-29
2026-01-30